Construct scenario
Turn a binder into a construct you can evaluate.
A team has an extracellular target binder and wants to explore receptor-mediated clearance. Consider a construct request with three GalNAc arms and a 20 Å linker span. The composition operation combines the supplied ligand with a span-selected PEG linker and GalNAc cluster, then requests structure verification and molecular descriptors. This makes the proposed construct specific enough to inspect and compare.
- Binder + 3 armsDefine the construct request
Supply the targeting ligand and a 20 Å span to examine.
- Structure + descriptorsCheck the composition
Return a valid molecular representation and computed descriptors when checks succeed. GalNAc stereochemistry and receptor recognition need their own checks.
- Binding → clearanceChoose the biological tests
Check target binding, receptor-dependent uptake and lysosomal target loss.
- An informative failure is an output · If the structure is invalid or the descriptor engine is unavailable, the operation reports the failure instead of filling in molecular properties. A construct that cannot be verified should be resolved before comparing its delivery assumptions.
- Compare the same therapeutic job · Published ASGPR-LYTACs already link target binders to GalNAc for degradation. For this candidate, compare the binder alone with the proposed conjugate, include receptor-dependence controls and test degradation separately from uptake. Computed size and polarity help frame those experiments; they do not establish clearance.
A construct you can interrogate
The design operation brings the targeting element, receptor-recruiting cluster and linker geometry into one candidate specification. Computed descriptors help examine the proposed construct. The biological question is whether target binding, receptor engagement, uptake and clearance cooperate in the intended setting.
ASGPR-targeting LYTACs are an established research approach. BioTwin’s current contribution is construct composition for a supplied targeting ligand, with the required biological tests kept distinct.
| Question | Familiar approach | BioTwin focus | Practical consequence |
|---|---|---|---|
| Mechanism | Published ASGPR-LYTAC work uses target binding and a GalNAc-based receptor ligand to recruit lysosomal clearance. | Compose the supplied targeting element, GalNAc cluster and a geometry-informed linker. | Assess a concrete construct within a known mechanism. |
| Starting information | The published approach requires a molecule that binds the extracellular target. | The targeting ligand is an input to this operation. | Binder discovery remains a separate job when no suitable ligand exists. |
| Evidence | Published examples include experimental target degradation. | Current construct output provides a design and computed descriptors; uptake and clearance need testing. | Plan assays for each missing step before interpreting target loss. |
This is a comparison of scope and evidence. Each proposed construct needs its own evidence for target binding, uptake and clearance.
Where this can change the program
A team with a suitable extracellular binder can investigate clearance as a different therapeutic job from occupancy alone. The immediate output is a construct to evaluate. Target depletion, receptor dependence and the resulting functional effect remain separate experimental questions.
Check the bridge and the destination
Linker analysis and hepatic-targeting models offer adjacent questions about the construct and its route. A joint analysis must use compatible assumptions; availability of the individual methods does not establish a completed delivery workflow.
- Multi-head geometry · Examine the relationship between linked binding elements. Multi-head geometry
- Hepatic targeting · Distinguish receptor-mediated uptake from hepatic activation. Hepatic targeting